191 related articles for article (PubMed ID: 35787506)
1. Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination.
Showers CR; Maurer JM; Khakshour D; Shukla M
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35787506
[TBL] [Abstract][Full Text] [Related]
2. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
3. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
4. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.
Yousaf AR; Cortese MM; Taylor AW; Broder KR; Oster ME; Wong JM; Guh AY; McCormick DW; Kamidani S; Schlaudecker EP; Edwards KM; Creech CB; Staat MA; Belay ED; Marquez P; Su JR; Salzman MB; Thompson D; Campbell AP;
Lancet Child Adolesc Health; 2022 May; 6(5):303-312. PubMed ID: 35216660
[TBL] [Abstract][Full Text] [Related]
5. Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination.
Belay ED; Godfred Cato S; Rao AK; Abrams J; Wilson WW; Lim S; Newton-Cheh C; Melgar M; DeCuir J; Webb B; Marquez P; Su JR; Meng L; Grome HN; Schlaudecker E; Talaat K; Edwards K; Barnett E; Campbell AP; Broder KR; Bamrah Morris S
Clin Infect Dis; 2022 Aug; 75(1):e741-e748. PubMed ID: 34849680
[TBL] [Abstract][Full Text] [Related]
6. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Vaccination in Two Children.
Karatzios C; Scuccimarri R; Chédeville G; Basfar W; Bullard J; Stein DR
Pediatrics; 2022 Aug; 150(2):. PubMed ID: 35614536
[TBL] [Abstract][Full Text] [Related]
7. Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination.
Jain E; Donowitz JR; Aarons E; Marshall BC; Miller MP
Emerg Infect Dis; 2022 May; 28(5):990-993. PubMed ID: 35275051
[TBL] [Abstract][Full Text] [Related]
8. Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination.
Wangu Z; Swartz H; Doherty M
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35354564
[TBL] [Abstract][Full Text] [Related]
9. Humoral cross-coronavirus responses against the S2 region in children with Kawasaki disease.
Monteiro A; Chang AJ; Welliver RR; Baron S; Hicar MD
Virology; 2022 Oct; 575():83-90. PubMed ID: 36088793
[TBL] [Abstract][Full Text] [Related]
10. Serological analysis of severe acute respiratory syndrome coronavirus 2 infection in children with Kawasaki disease.
Kondo Y; Kawamura Y; Hattori F; Nakai H; Saito K; Suzuki D; Kozawa K; Yoshikawa T
J Med Virol; 2023 Nov; 95(11):e29274. PubMed ID: 38009251
[TBL] [Abstract][Full Text] [Related]
11. A Suspected Case of Multisystem Inflammatory Disease in Children Following COVID-19 Vaccination: A Case Report and Systematic Literature Review.
Lee JS; Cho KS; Choe YJ
Pediatr Infect Dis J; 2022 Nov; 41(11):e456-e460. PubMed ID: 36102702
[TBL] [Abstract][Full Text] [Related]
12. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
Zhang QY; Xu BW; Du JB
World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
[TBL] [Abstract][Full Text] [Related]
13. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 infection in the context of Kawasaki disease and multisystem inflammatory syndrome in children.
Folga BA; Karpenko CJ; Grygiel-Górniak B
Med Microbiol Immunol; 2023 Feb; 212(1):3-12. PubMed ID: 36396785
[TBL] [Abstract][Full Text] [Related]
15. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): Distinct from Kawasaki disease or part of the same spectrum?
Santaniello M; Matucci-Cerinic C; Natoli V; Trincianti C; Ridella F; Ravelli A
Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):102-104. PubMed ID: 35080303
[TBL] [Abstract][Full Text] [Related]
16. Multisystem Inflammatory Syndrome in Adults (MIS-A) After COVID-19 Infection and Recent Vaccination with Recombinant Adenoviral Vector Encoding the Spike Protein Antigen of SARS-CoV-2 (ChAdOx1 nCoV-19, Vaxzevria).
Ehikhametalor K; Deans-Minott J; Duncan JP
J Intensive Care Med; 2023 Feb; 38(2):232-237. PubMed ID: 35979616
[TBL] [Abstract][Full Text] [Related]
17. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
Lee PY; Day-Lewis M; Henderson LA; Friedman KG; Lo J; Roberts JE; Lo MS; Platt CD; Chou J; Hoyt KJ; Baker AL; Banzon TM; Chang MH; Cohen E; de Ferranti SD; Dionne A; Habiballah S; Halyabar O; Hausmann JS; Hazen MM; Janssen E; Meidan E; Nelson RW; Nguyen AA; Sundel RP; Dedeoglu F; Nigrovic PA; Newburger JW; Son MBF
J Clin Invest; 2020 Nov; 130(11):5942-5950. PubMed ID: 32701511
[TBL] [Abstract][Full Text] [Related]
18. Atypical Kawasaki syndrome in COVID-19 infection: a case report of a multisystem inflammatory syndrome in a child (MIS-C).
Sylverken J; Afari P; Martyn-Dickens C; Owusu SA; Oppong E; Akwetey F; Mensah E; Mahama H; Owusu SK; Antwi S
Ghana Med J; 2021 Jun; 55(2 Suppl):64-67. PubMed ID: 35233117
[TBL] [Abstract][Full Text] [Related]
19. Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review.
Mastrolia MV; De Cillia C; Orlandi M; Abu-Rumeileh S; Maccora I; Maniscalco V; Marrani E; Pagnini I; Simonini G
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004076
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.
Becerril-Gaitan A; Vaca-Cartagena BF; Ferrigno AS; Mesa-Chavez F; Barrientos-Gutiérrez T; Tagliamento M; Lambertini M; Villarreal-Garza C
Eur J Cancer; 2022 Jan; 160():243-260. PubMed ID: 34794855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
